5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 6 studies
Studies (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Trials (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Recent Studies (post-2010) (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Studies (n-methyl-3,4-methylenedioxyamphetamine) | Trials (n-methyl-3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine) |
---|---|---|---|---|---|
218 | 0 | 12 | 4,276 | 211 | 1,392 |
Protein | Taxonomy | 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole (IC50) | n-methyl-3,4-methylenedioxyamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.9351 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.1761 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.06 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.7609 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callaway, CW; Geyer, MA | 1 |
Callaway, CW; Geyer, MA; Rempel, NL | 1 |
Chen, JP; Gardner, E; Hen, R; Scearce-Levie, K | 1 |
Compan, V; Crosson, C; Daszuta, A; Hen, R; Scearce-Levie, K | 1 |
Aronsen, D; Bukholt, N; Schenk, S | 1 |
Aronsen, D; Schenk, S | 1 |
6 other study(ies) available for 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Brain; Drug Interactions; Drug Tolerance; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1992 |
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |
5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aggression; Animals; Behavior, Animal; Cocaine; Disease Models, Animal; Dopamine; Dopamine Antagonists; Feeding Behavior; gamma-Aminobutyric Acid; Indoles; Mental Disorders; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Substance-Related Disorders | 1999 |
Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine.
Topics: Animals; Blotting, Northern; Brain; Enkephalins; Immunohistochemistry; Indoles; Mice; Mice, Knockout; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2003 |
Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.
Topics: Animals; Dose-Response Relationship, Drug; Humans; Indoles; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Self Administration; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists | 2016 |
MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 2016 |